A long-term controlled release of the drug for osteoporosis from the surface of titanium implants coated with calcium zeolite
- 3 June 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 5 (15) , 5718-5725
Abstract
The aim of this study was to prepare an implant material enabling a slow, gradual and gentle release of risedronate.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2017/27/N/ST8/00307)
This publication has 47 references indexed in Scilit:
- Biomedical applications of bisphosphonatesJournal of Controlled Release, 2013
- Antibacterial and anti-adhesive zeolite coatings on titanium alloy surfaceMicroporous and Mesoporous Materials, 2011
- Bisphosphonates: The first 40yearsBone, 2011
- Role of ethanol in sodalite crystallization in an ethanol–Na2O–Al2O3–SiO2–H2O systemCrystEngComm, 2011
- Thermostability of hydroxy sodalite in view of membrane applicationsMicroporous and Mesoporous Materials, 2010
- Osteoconductive and Osteoinductive Properties of Zeolite MFI Coatings on Titanium AlloysAdvanced Functional Materials, 2009
- Biocompatibility of corrosion-resistant zeolite coatings for titanium alloy biomedical implantsActa Biomaterialia, 2009
- Synthesis of Zeolite From Thermally Treated SedimentIndustrial & Engineering Chemistry Research, 2007
- Surface modification of titanium, titanium alloys, and related materials for biomedical applicationsMaterials Science and Engineering: R: Reports, 2004
- Structural, compositional and acidic characteristics of nanosized amorphous or partially crystalline ZSM-5 zeolite-based materialsMicroporous and Mesoporous Materials, 2004